Researchers in Cuttack have successfully validated AI-generated enzymes in plants, marking a major leap forward for Indian biotechnology and agricultural innovation.
The Centre for Cellular and Molecular Platforms has been named a Focused Research Organisation under the RDI Fund, with a half‑billion‑rupee commitment to nurture high‑risk biotechnology ventures.
The Embassy of India in Berlin facilitated a technology transfer agreement between Neovii Biotech and VINS Bioproducts during the Indo-German Health Leadership Dialogue.
The annual contest drew over 3,200 entries across India, with Biocon's Kiran Mazumdar Shaw calling for rapid scaling to build a multi-trillion-dollar bioeconomy.